Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Sonos Charts. Click Here for more Sonos Charts.](/p.php?pid=staticchart&s=N%5ESONO&p=8&t=15)
SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in
hand-carried ultrasound for the point-of-care, today reported that
Bernard J. Pitz, Senior Vice President and Chief Financial Officer has
departed SonoSite at the request of the company. Michael J. Schuh,
currently Vice President, Finance and Business Process, is returning as
CFO. Mr. Schuh served as SonoSite’s CFO from
July 2000 until May 2008.
Separately, SonoSite also reported that revenue grew approximately 23%
to over $61 million in the third quarter, ended September 30, 2008, as
compared to the same quarter in 2007, and that the company expects to
exceed consensus earnings estimates with strong cash flow.
Third quarter financial results are preliminary. The company will report
third quarter and nine months financial results on Thursday, October 30,
2008 at the close of market.
About SonoSite
SonoSite, Inc. (www.sonosite.com)
is the innovator and world leader in hand-carried ultrasound.
Headquartered near Seattle, the company is represented by ten
subsidiaries and a global distribution network in over 100 countries.
SonoSite’s small, lightweight systems are
expanding the use of ultrasound across the clinical spectrum by
cost-effectively bringing high performance ultrasound to the point of
patient care. The company employs over 600 people worldwide.
Forward-looking Information and the
Private Litigation Reform Act of 1995
Certain statements in this press release relating to the market
acceptance of our products, possible future sales relating to expected
orders, and our future financial position and operating results are “forward-looking
statements” for the purposes of the safe
harbor provisions of the Private Securities Litigation Reform Act of
1995. These forward-looking statements are based on the opinions and
estimates of our management at the time the statements are made and are
subject to risks and uncertainties that could cause actual results to
differ materially from those expected or implied by the forward-looking
statements. These statements are not guaranties of future performance
and are subject to known and unknown risks and uncertainties and are
based on potentially inaccurate assumptions. Factors that could affect
the rate and extent of market acceptance of our products, the receipt of
expected orders, and our financial performance include our ability to
successfully manufacture, market and sell our ultrasound systems, our
ability to accurately forecast customer demand for our products, our
ability to manufacture and ship our systems in a timely manner to meet
customer demand, variability in quarterly results caused by the timing
of large project orders from governmental or international entities and
the seasonality of hospital purchasing patterns, timely receipts of
regulatory approvals to market and sell our products, regulatory and
reimbursement changes in various national health care markets,
constraints in government and public health spending, the ability of our
distribution partners and other sales channels to market and sell our
products and any changes to such channels, the impact of patent
litigation, our ability to execute our acquisition strategy, the effect
of transactions and activities associated with our issuance of senior
convertible debt in July 2007 on the market price of our common stock,
and as well as other factors contained in the Item 1A. “Risk
Factors” section of our most recent Annual
Report on Form 10-K filed with the Securities and Exchange Commission.
We caution readers not to place undue reliance upon these
forward-looking statements that speak only as to the date of this
release. We undertake no obligation to publicly revise any
forward-looking statements to reflect new information, events or
circumstances after the date of this release or to reflect the
occurrence of unanticipated events.